10-Q · October 31, 2025
Omega reported Q3 total revenues of $311.6M, up 12.9% from $276.0M a year ago, driven by higher rental income and interest income. Diluted EPS rose to $0.59 from $0.42 in Q3 2024 (an increase of $0.17, ~40.5%), and…
Earnings analysis · 10-Q
OHI earnings analysis
Filed April 29, 2026 · Our reading of the company's report
The latest report
Omega Healthcare Investors, Inc. reported a robust Q1 2026 with significant growth in both revenue and EPS, outperforming consensus expectations. Revenue totaled $322.96 million, representing a 16.7% increase…
Read full summary
Omega Healthcare Investors, Inc. reported a robust Q1 2026 with significant growth in both revenue and EPS, outperforming consensus expectations. Revenue totaled $322.96 million, representing a 16.7% increase year-over-year while diluted EPS rose to $0.82, beating estimates by 6.5%. Management has also raised its Adjusted FFO guidance for the year, indicating a strong operational outlook despite challenges in the sector.
Gross and operating margin
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
How we read each report
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Reported figures
- Earnings per share
- $0.82
What stood out
-
Revenue Growth Year-over-Year
Q1 2026 revenue increased to $322.96 million, up 16.7% from $276.79 million in Q1 2025.
-
EPS Beat Consensus Estimates
Diluted EPS for Q1 2026 was $0.82, exceeding the consensus estimate of $0.77 by 6.5%.
-
Adjusted FFO Guidance Raised
Management raised the full-year Adjusted FFO midpoint from $3.20 to $3.22.
-
Strong Operating Cash Flow
Operating cash flow increased 18.4% to $215.5 million from $181.95 million year-over-year.
-
Decrease in Total Liabilities
Total liabilities decreased to $4.78 billion, down from $4.61 billion at the end of 2025.
-
Cash Position Remains Strong
Cash and cash equivalents totaled $26.15 million as of March 31, 2026, slightly down from $27.02 million at the end of 2025.
What to watch
-
Continued Operator Bankruptcy Issues
Genesis Healthcare, under Chapter 11 bankruptcy, poses risks to rent collection and operational stability.
-
High Dependency on Fewer Operators
20 operators are on a cash basis for rental revenue recognition, representing 21.8% of revenues, indicating potential income volatility.
-
Increased Debt Levels
Revolving credit facility has increased to $425 million from $242 million, raising concern about leverage.
Management's outlook
Management increased full-year Adjusted FFO guidance to $3.22 per share.
Earlier filings 4
10-Q · August 2, 2024
Omega reported stronger Q2 operating results with net income of $117,079,000 and diluted EPS of $0.45 (Q2 2023: $61,521,000 and $0.25), driven by higher interest income and a $14.2M recovery for credit losses. Operating…
10-Q · May 3, 2024
Omega Healthcare reported Q1 2024 total revenues of $243,299,000 (up from $218,202,000 a year ago, +$25,097,000 or +11.5%) and diluted EPS of $0.27 versus $0.15 in Q1 2023. Operating cash flow strengthened to…
10-K · February 12, 2024
Omega Healthcare (OHI) reported total revenues of $949,740,000 in 2023, up from $878,244,000 in 2022, driven by higher rental income. The company maintains a large, diversified portfolio of 891 healthcare facilities…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.